A stem cell therapy that repairs damaged cells after a heart attack, injectable bone that can be used to fill voids in bone, and a technique to determine which patients will respond to drugs in development were among the winners at an award ceremony for medical innovation held on 2 December in London by the Medical Futures group.

The stem cell therapy, developed by a team at the National Heart and Lung Institute at Imperial College London, aims to take stem or progenitor cells from a patient’s heart muscle, grow them in the laboratory, and then graft them back into the injured muscle.

The team, comprising Michael Schneider, Dorian Haskard, and Ranil de Silva, won the cardiovascular …